Immunovant, Inc. (IMVT)
NASDAQ·Healthcare·Biotechnology
$33.43
+0.04%
Mkt Cap $6.49B
Analyst Ratings
Buy
6
Hold
3
Sell
0
Price Target (9 analysts)
$45.50
Range $41.00 – $50.00
Implied Upside
+36.1%
Consensus $45.50 vs current $33.43
NASDAQ·Healthcare·Biotechnology
$33.43
+0.04%
Mkt Cap $6.49B
Buy
6
Hold
3
Sell
0
Price Target (9 analysts)
$45.50
Range $41.00 – $50.00
+36.1%
Consensus $45.50 vs current $33.43